ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE72.3

E72.3

Billable

Disorders of lysine and hydroxylysine metabolism

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E72.3 is a billable code used to indicate a diagnosis of disorders of lysine and hydroxylysine metabolism.

Key Diagnostic Point:

Disorders of lysine and hydroxylysine metabolism are rare metabolic conditions characterized by the body's inability to properly metabolize the amino acids lysine and hydroxylysine. These disorders can lead to a variety of clinical manifestations, including growth retardation, skeletal abnormalities, and neurological deficits. The underlying cause is often due to enzyme deficiencies that disrupt the normal metabolic pathways of these amino acids. Lysine is essential for protein synthesis and plays a critical role in various physiological functions, including collagen formation and hormone production. Hydroxylysine, a derivative of lysine, is primarily involved in the structural integrity of collagen. Deficiencies in the enzymes responsible for the metabolism of these amino acids can result in the accumulation of toxic metabolites, leading to cellular dysfunction and systemic effects. Diagnosis typically involves biochemical testing to measure amino acid levels in blood and urine, alongside genetic testing to identify specific enzyme deficiencies. Management may include dietary modifications, supplementation, and supportive therapies to address symptoms and improve quality of life.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Limited awareness of the condition among healthcare providers.
  • Variability in clinical presentation and severity.
  • Need for biochemical and genetic testing for accurate diagnosis.
  • Potential overlap with other metabolic disorders.

Audit Risk Factors

  • Inadequate documentation of enzyme testing results.
  • Failure to specify the type of metabolic disorder.
  • Misclassification of related amino acid disorders.
  • Lack of detailed clinical history supporting the diagnosis.

Specialty Focus

Medical Specialties

Genetics

Documentation Requirements

Detailed family history and genetic testing results.

Common Clinical Scenarios

Patients with unexplained developmental delays or metabolic crises.

Billing Considerations

Ensure genetic counseling is documented for affected families.

Pediatrics

Documentation Requirements

Growth charts and developmental assessments.

Common Clinical Scenarios

Infants with failure to thrive or unusual skeletal findings.

Billing Considerations

Document any dietary interventions or referrals to nutritionists.

Coding Guidelines

Inclusion Criteria

Use E72.3 When
  • Follow ICD
  • CM coding guidelines for metabolic disorders, ensuring accurate documentation of the condition, including any associated symptoms or complications
  • Include relevant laboratory results and genetic testing outcomes to support the diagnosis

Exclusion Criteria

Do NOT use E72.3 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

84162CPT Code

Amino acid analysis

Clinical Scenario

Used to confirm diagnosis of lysine metabolism disorder through blood or urine tests.

Documentation Requirements

Document the reason for testing and any relevant clinical findings.

Specialty Considerations

Geneticists and metabolic specialists should ensure comprehensive documentation of test results.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including E72.3, which enhances the ability to track and manage these rare conditions more effectively.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including E72.3, which enhances the ability to track and manage these rare conditions more effectively.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including E72.3, which enhances the ability to track and manage these rare conditions more effectively.

Resources

Clinical References

  • •
    National Organization for Rare Disorders (NORD)

Coding & Billing References

  • •
    National Organization for Rare Disorders (NORD)

Frequently Asked Questions

What are the common symptoms of disorders of lysine and hydroxylysine metabolism?

Common symptoms include growth retardation, skeletal abnormalities, neurological deficits, and metabolic crises. Symptoms can vary widely based on the severity of the enzyme deficiency.